Streetbeat News

MBXBF

Microbix Biosystems Inc.

Industry

Research and Development in Biotechnology

Open

0.25

Mkt cap

33M

Volume

High

0.25

P/E Ratio

8.10

52-wk high

0.33

Low

0.24

Div yield

N/A

52-wk low

0.20

Microbix has scheduled the release of its Q4 Fiscal 2024 results and a subsequent webinar discussion for December 19, 2024. This announcement is relevant for investors tracking the company's performance.

Portfolio Pulse from

December 12, 2024 | 12:15 pm

Microbix Biosystems Inc. has announced a Normal Course Issuer Bid to repurchase and cancel up to 5% of its outstanding common shares, aiming to enhance shareholder value.

Portfolio Pulse from

December 05, 2024 | 12:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.